Employers who recognize the impact of migraine may help to improve workplace productivity

Migraine :: Employers who recognize the impact of migraine may help to improve workplace productivity

Migraines take a toll on employers as well ? up to $28.7 billion in annual direct and indirect healthcare costs can be attributed to migraine-related losses in productivity. Data presented today at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.

The data also suggested workers consider potential treatment options that may help them prevent or reduce the frequency of migraine attacks.

The first of three analyses sponsored by Ortho-McNeil Neurologics, Inc. found that employers who actively screen for migraine may help identify those undiagnosed with the condition. The researchers also evaluated the total burden of migraine in the workplace and found that more than 50 percent of the migraine sufferers surveyed experienced moderate to severe disability due to the condition, often affecting job performance and leading to missed workdays. The third analysis examined the impact of preventive treatment on workers who suffer from frequent migraines and suggested that use of TOPAMAX? (topiramate) may lead to fewer missed workdays and improve workplace productivity.

"Migraine can have a significant impact in the workplace," said study investigator Jennifer Lofland, PharmD, MPH, Ph.D., project director, Department of Health Policy, Jefferson Medical College of Thomas Jefferson University.

"If migraine can be effectively managed during the workday, it may lead to cost savings for employers over the long run. One approach patients may want to consider is taking a preventive medication to help reduce the frequency of migraine attacks and potentially lead to more migraine-free days."

Screening for Migraine in the Workplace

Researchers determined that the use of a brief, online screener may help to detect those undiagnosed for migraine in an employer setting and is easy to administer. Researchers from the Center for Health Economics and Policy, United BioSource Corporation, developed an online tool based on a validated screener (Lainez et al.), to help determine the prevalence of migraine in the workplace.

Three large employers in the U.S. were recruited to participate in the online study that compared the screening results with patient-reported migraine diagnoses. The results revealed that more than 90 percent of employees who reported a previous migraine diagnosis screened positive for the condition. In addition, nearly 30 percent of respondents who met the screener criteria for migraine were undiagnosed.

Burden of Migraine in Employer Settings

In the same study, researchers aimed to assess the total burden of migraine in the workplace including impact on productivity. The researchers compared employee responses to the online screener with results from a baseline survey investigating migraine frequency and severity, treatment patterns and total impact of migraine at work during a three-month period.

Study results revealed that more than 50 percent of people with migraines experienced moderate to severe disability in the previous three months due to the condition. On average, one workday was missed per employee due to migraine, while the average days worked while having a migraine was 8.9 days. Direct medical costs were $200,410 per 1,000 migraine sufferers and indirect costs, including absenteeism (hours absent from work) and presenteeism (hours worked with migraine with reduced efficiency), were $404,660 per 1,000 migraine sufferers. From a treatment perspective, more than 70 percent of respondents reported having frequent and/or disabling migraines and may be candidates for preventive treatment. However, only 15 percent were taking a daily preventive migraine therapy. Forty-eight percent reported taking a prescription medication for migraine symptom relief, and 79 percent reported taking a non-prescription medication.

TOPAMAX Improved Workplace Productivity ? Pooled Results from Three Trials

Results of this data analysis conducted by Philadelphia?s Thomas Jefferson University, suggested that 100 mg per day of TOPAMAX, approved by the U.S. Food and Drug Administration (FDA) for migraine prevention in adults, may help to improve workplace productivity. Researchers examined pooled results from three different trials, including data recently published in The Journal of Occupational and Environmental Medicine. The findings suggested productivity improved more than two-fold among workers after beginning treatment with TOPAMAX (total lost productivity time was 13.5 hours per month prior to TOPAMAX therapy vs. 5.1 hours per month following TOPAMAX therapy).

Migraine sufferers taken from three previous phase III clinical trials were evaluated as part of the study. All were clinically diagnosed with migraine and experienced at least three to 12 migraines per month. In this analysis, the respondents completed a five-item survey each time they experienced a migraine attack, which evaluated absenteeism and presenteeism. The analysis was limited to respondents from the clinical trials who were employed, and the researchers only captured lost work hours observed during episodes of migraine.




(Migraine :: Employers who recognize the impact of migraine may help to improve workplace productivity published at SpiritIndia on Friday, May 4, 2007)

Migraine

Search more information on Migraine, Migraine books

Recently posted related articles on Migraine :

1. Migraine :: Migraines ? options to prevent and treat the pounding pain
2. Depression :: Depression in women with migraine linked to childhood abuse
3. Migraine :: Women with migraines and visual symptoms may have higher stroke risk
4. Migraine :: Why women get more migraines than men
5. Migraine :: FDA issues second approvable letter for Trexima
6. Migraine :: Teenagers from low income families at greater risk of migraine
7. Migraine :: Impact of family income on prevalence of migraine in adolescents
8. Migraine :: Trexima provided relief of both traditional & non-traditional migraine symptoms
9. Migraine :: Employers who recognize the impact of migraine may help to improve workplace productivity
10. Migraine :: Migraine in teens & young may boost suicide risk

Most related articles:

- Migraine :: Employers who recognize the impact of migraine may help to improve workplace productivity
- Migraine :: Fear of migraine destroys quality of life for men - 14.9
- Migraine :: Trexima provided relief of both traditional & non-traditional migraine symptoms - 14.8
- Migraine :: Teenagers from low income families at greater risk of migraine - 14.7
- Migraine :: Essential Guide to Understanding and Treating Migraines - 14.5
- Migraine :: Migraine may protect memory & prevent cognitive decline - 14.4
- Migraine :: Migraine Magic Massaging Eye Mask - 14.2
- Migraine :: Impact of family income on prevalence of migraine in adolescents - 13.4
- Migraine :: Surgery helps relieve migraines - 13.3
- Depression :: Depression in women with migraine linked to childhood abuse - 12.3

Migraine - recent related articles/news stories:

- Forehead lifts can cure headaches and migraines
- Children with chronic daily headache may improve with time
- Migraine in women increases brain lesions risk
- Migraine patients can exercise now
- Headache and migraine linked to hot weather, air pollution

»»   Alcohol :: Alcohol advertising and marketing associated with adolescent drinking
««   Autism :: Social behavior differs in children with family history of autism

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com